相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium
Zhe Zhou et al.
CELL METABOLISM (2011)
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
Harvey White et al.
AMERICAN HEART JOURNAL (2010)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
A genome-wide perspective of genetic variation in human metabolism
Thomas Illig et al.
NATURE GENETICS (2010)
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma
Constantinos C. Tellis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Expression of lipoprotein-associated phospholipase A2 in carotid artery plaques predicts long-term cardiac outcome
Joerg Herrmann et al.
EUROPEAN HEART JOURNAL (2009)
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker
Marshall A. Corson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages
Katarina E. Olofsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque
Patrick W. Serruys et al.
CIRCULATION (2008)
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Robert L. Wilensky et al.
NATURE MEDICINE (2008)
Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
Dallit Mannheim et al.
STROKE (2008)
Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3
Chi-Lou Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects
Margaretha Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses
Yi Shi et al.
ATHEROSCLEROSIS (2007)
Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells
Nambi Aiyar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
Frank D. Kolodgie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease
E Emanuele et al.
ATHEROSCLEROSIS (2006)
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction
DE Mosedale et al.
ATHEROSCLEROSIS (2005)
Association between Lp-PLA2 and coronary artery disease:: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
N Khuseyinova et al.
ATHEROSCLEROSIS (2005)
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages
YI Miller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Role of lipoprotein-associated phospholipase A2 in atherosclerosis -: Biology, epidemiology, and possible therapeutic target
A Zalewski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population -: Results from the 14-year follow-up of a large cohort from southern Germany
W Koenig et al.
CIRCULATION (2004)
Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism
GZ Fei et al.
ATHEROSCLEROSIS (2003)
Changes related to age and the extracellular matrix cerebrovascular symptoms in of human carotid plaques
I Gonçalves et al.
STROKE (2003)
Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines
G Murugesan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells
JX Rong et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism
M Takahashi et al.
ATHEROSCLEROSIS (2002)
Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL
CC Hsieh et al.
ATHEROSCLEROSIS (2000)
分享论文
